Today is Friday, Jul. 20, 2018

Department of Environmental Health

Center for Environmental Genetics

About Us

One of the nation's first environmental health science research programs and the region's only academic center focusing in this field, the CEG is fast becoming a global leader in the study of gene-environment interactions (GxE) and the translation of ground-breaking research into advances in primary prevention and human health. Our mission: To conduct innovative, multidisciplinary GXE research and translate discoveries to regional and global disease prevention with healthier environments and empowered communities. Toward these ends, CEG investigators, trainees and collaborators are currently studying the role of GXE in

  1. endocrine disruption and cancer;
  2. immune and allergic diseases;
  3. cardiovascular and lipid disorders; and
  4. neurology and behavior disorders.
Our nationally and internationally recognized researchers devote special attention to the early origins of disease; windows of susceptibility (e.g., in utero, puberty); the interplay between genetics and epigenetics; genomics, epigenomics and other -omics (proteomics, metabolomics, metagenomics, and metallomics); the influence of lifestyle modifiers such as diet or stress on epigenetic reprogramming; and, finally, the data void related to continuous lifelong editing of early developmental programming and the potential for transgenerational effects. (Click here for CEG News)

Illustration of the integration and global impact of CEG Cores

 

The CEG is led by Shuk-Mei Ho, PhD, Jacob G. Schmidlapp Professor & Chair of the Department of Environmental Health, Associate Dean for Basic Research in the UC College of Medicine, and Director of the Cincinnati Cancer Center. In April 2015 Dr. Ho received the University's prestigious Rieveschl Award for Distinguished Scientific Research; in 2017 she became a recipient of the Drake Medal, the highest honor conferred by the College of Medicine. She is an internationally recognized leader in endocrine disruptor and cancer research and has been profiled in the Journal of Endocrinology and Cancer, August 2014; PMID 24928923.